Last Posted: Apr 17, 2020
- Gene Expression Profile Testing for Thin Melanoma- Evidence to Support Clinical Use Remains Thin
CL Kovarik et al, JAMA Dermatology, April 15, 2020 - Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material.
Steeghs Elisabeth M P et al. BMC cancer 2020 Apr 20(1) 291 - Molecular risk prediction in cutaneous melanoma: a meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
Greenhaw Bradley N et al. Journal of the American Academy of Dermatology 2020 Mar - Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.
Goldberg Sarah B et al. The Lancet. Oncology 2020 Apr - Machine Learning in Melanoma Diagnosis. Limitations About to be Overcome.
González-Cruz C et al. Actas dermo-sifiliograficas 2020 Apr - Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.
Liang Winnie S et al. The oncologist 2019 24(2) 219-228 - Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
Garola Robert et al. Pathology, research and practice 2019 Oct 215(10) 152550 - Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel.
Malapelle Umberto et al. Frontiers in oncology 2020 10236 - The use of circulating cell-free tumor DNA in routine diagnostics of metastatic melanoma patients.
Knuever Jana et al. Scientific reports 2020 Mar 10(1) 4940 - DePicT Melanoma Deep-CLASS: a deep convolutional neural networks approach to classify skin lesion images.
Nasiri Sara et al. BMC bioinformatics 2020 Mar 21(Suppl 2) 84
.png)
No hay comentarios:
Publicar un comentario